BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 24264312)

  • 1. The expression of BTG1 is downregulated in NSCLC and possibly associated with tumor metastasis.
    Sun GG; Lu YF; Cheng YJ; Hu WN
    Tumour Biol; 2014 Apr; 35(4):2949-57. PubMed ID: 24264312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BTG1 expression correlates with the pathogenesis and progression of breast carcinomas.
    Sheng SH; Zhao CM; Sun GG
    Tumour Biol; 2014 Apr; 35(4):3317-26. PubMed ID: 24272202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of BTG1 in hepatocellular carcinoma and its correlation with cell cycles, cell apoptosis, and cell metastasis.
    Sun GG; Lu YF; Cheng YJ; Yang CR; Liu Q; Jing SW; Han XC
    Tumour Biol; 2014 Dec; 35(12):11771-9. PubMed ID: 25173640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BTG1 underexpression is an independent prognostic marker in esophageal squamous cell carcinoma.
    Sun GG; Wang YD; Cheng YJ; Hu WN
    Tumour Biol; 2014 Oct; 35(10):9707-16. PubMed ID: 24969561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The expression of BTG1 is downregulated in nasopharyngeal carcinoma and possibly associated with tumour metastasis.
    Sun GG; Wang YD; Cheng YJ; Hu WN
    Mol Biol Rep; 2014 Sep; 41(9):5979-88. PubMed ID: 24985971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proto-oncogene Wip1, a member of a new family of proliferative genes in NSCLC and its clinical significance.
    Fu Z; Sun G; Gu T
    Tumour Biol; 2014 Apr; 35(4):2975-81. PubMed ID: 24272082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EMP1 inhibits nasopharyngeal cancer cell growth and metastasis through induction apoptosis and angiogenesis.
    Sun GG; Lu YF; Fu ZZ; Cheng YJ; Hu WN
    Tumour Biol; 2014 Apr; 35(4):3185-93. PubMed ID: 24292952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BTG1 expression in thyroid carcinoma: diagnostic indicator and prognostic marker.
    Lu YF; Sun GG; Liu Q; Yang CR; Cheng YJ
    Int J Oncol; 2014 Oct; 45(4):1574-82. PubMed ID: 25017022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An antiproliferative gene FLNA regulates migration and invasion of gastric carcinoma cell in vitro and its clinical significance.
    Sun GG; Sheng SH; Jing SW; Hu WN
    Tumour Biol; 2014 Mar; 35(3):2641-8. PubMed ID: 24241900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EMP1 regulates caspase-9 and VEGFC expression and suppresses prostate cancer cell proliferation and invasion.
    Sun GG; Wang YD; Cui DW; Cheng YJ; Hu WN
    Tumour Biol; 2014 Apr; 35(4):3455-62. PubMed ID: 24338711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA BX357664 inhibits the proliferation and invasion of non-small cell lung cancer cells.
    Yang J; Du YM; Li B
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):660-669. PubMed ID: 30720174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EMP1, a member of a new family of antiproliferative genes in breast carcinoma.
    Sun GG; Wang YD; Lu YF; Hu WN
    Tumour Biol; 2014 Apr; 35(4):3347-54. PubMed ID: 24402572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absent expression of FLNA is correlated with poor prognosis of nasopharyngeal cancer.
    Sun GG; Lu YF; Cheng YJ; Hu WN
    Tumour Biol; 2014 Apr; 35(4):2967-74. PubMed ID: 24218340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of N-Acetylglucosaminyltransferase GCNT3 by miR-302b-3p Decreases Non-Small Cell Lung Cancer (NSCLC) Cell Proliferation, Migration and Invasion.
    Li Q; Ran P; Zhang X; Guo X; Yuan Y; Dong T; Zhu B; Zheng S; Xiao C
    Cell Physiol Biochem; 2018; 50(3):987-1004. PubMed ID: 30355927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-4299 suppresses non-small cell lung cancer cell proliferation, migration and invasion through modulating PTEN/AKT/PI3K pathway.
    Yang WB; Zhang WP; Shi JL; Wang JW
    Eur Rev Med Pharmacol Sci; 2018 Jun; 22(11):3408-3414. PubMed ID: 29917192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of Wild-Type p53-Induced Phosphatase 1 Confers Poor Prognosis of Patients with Nasopharyngeal Carcinoma.
    Sun GG; Zhang J; Ma XB; Wang YD; Cheng YJ; Hu WN
    Pathol Oncol Res; 2015 Apr; 21(2):283-91. PubMed ID: 25060857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BTG1 expression correlates with pathogenesis, aggressive behaviors and prognosis of gastric cancer: a potential target for gene therapy.
    Zheng HC; Li J; Shen DF; Yang XF; Zhao S; Wu YZ; Takano Y; Sun HZ; Su RJ; Luo JS; Gou WF
    Oncotarget; 2015 Aug; 6(23):19685-705. PubMed ID: 26050197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of RCN1 correlates with poor prognosis and progression in non-small cell lung cancer.
    Chen X; Shao W; Huang H; Feng X; Yao S; Ke H
    Hum Pathol; 2019 Jan; 83():140-148. PubMed ID: 30172915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased microRNA-224 and its clinical significance in non-small cell lung cancer patients.
    Zhu D; Chen H; Yang X; Chen W; Wang L; Xu J; Yu L
    Diagn Pathol; 2014 Nov; 9():198. PubMed ID: 25410592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation of NKD1 increases the invasive potential of non-small-cell lung cancer and correlates with a poor prognosis.
    Zhang S; Wang Y; Dai SD; Wang EH
    BMC Cancer; 2011 May; 11():186. PubMed ID: 21599923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.